A Clinical Double Blind, Randomized Study of the Efficacy of Hyperuricemia Treatment With Anserine Product.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00208000|
Recruitment Status : Unknown
Verified September 2005 by China Medical University Hospital.
Recruitment status was: Recruiting
First Posted : September 21, 2005
Last Update Posted : November 29, 2010
|Condition or disease||Intervention/treatment||Phase|
|"Hyperuricemia,Anserine"||Drug: Marine active||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Intervention Model:||Parallel Assignment|
|Study Start Date :||July 2004|
|Estimated Study Completion Date :||April 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00208000
|Contact: Chiu-Shong Liu, Director||886-4-22052121 ext email@example.com|
|Contact: Kuo-Chin Huang||886-4-22052121 ext firstname.lastname@example.org|
|China Medical University Hospita||Recruiting|
|Taichung, Taiwan, 404|
|Contact: Chiu-Shong Liu, PhD 886-4-22052121 ext 5068 email@example.com|
|Contact: Kuo-Chin Huang, PhD 886-4-22052121 ext 5068 firstname.lastname@example.org|
|Principal Investigator:||Chiu-Shong Liu, Director||Family Medicine, China Medical University Hospital|